What is the price-to-earnings ratio of Glaukos?
The price-earnings ratio of Glaukos is currently -47.04.
Glaukos P/E 2024
Glaukos P/E
-47.04
Ticker
GKOS
ISIN
US3773221029
WKN
A14VCK
As of Oct 4, 2024, Glaukos's P/E ratio was -47.04, a 122.31% change from the -21.16 P/E ratio recorded in the previous year.
The Glaukos P/E history
Glaukos Aktienanalyse
What does Glaukos do?
Glaukos Corp is a medical technology company specializing in developing devices and therapies for treating eye diseases. It was founded in 1998 by employees of the ophthalmology center at the University of California San Francisco. The company focuses on utilizing new technologies and therapies to improve the vision quality of patients. They have developed innovative products for diagnosing and treating various eye conditions, including glaucoma. Their core business involves manufacturing and distributing medical devices for glaucoma treatment, such as the iStent implant. They have also partnered with other institutions to advance research and development in the field of ophthalmology. In 2018, Glaukos Corp acquired the German manufacturer Markt II Medical, expanding their product offerings for a wider range of eye diseases. In summary, Glaukos Corp is an innovative medical technology company that aims to enhance patients' vision quality while minimizing the risks of eye surgery. Glaukos ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/E Details
Deciphering Glaukos's P/E Ratio
The Price to Earnings (P/E) Ratio of Glaukos is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.
Year-to-Year Comparison
Assessing Glaukos's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.
Impact on Investments
The P/E ratio of Glaukos is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.
Interpreting P/E Ratio Fluctuations
Fluctuations in Glaukos’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.
Frequently Asked Questions about Glaukos stock
How has the price-earnings ratio of Glaukos changed compared to last year?
The price-to-earnings ratio of Glaukos has increased by 122.31% increased compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Glaukos high compared to other companies?
Yes, the price-to-earnings ratio of Glaukos is high compared to other companies.
How does an increase in the price-earnings ratio of Glaukos affect the company?
An increase in the price-earnings ratio of Glaukos would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Glaukos affect the company?
A decrease in the price-earnings ratio of Glaukos would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Glaukos?
Some factors that influence the price-earnings ratio of Glaukos are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Glaukos pay?
Over the past 12 months, Glaukos paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Glaukos is expected to pay a dividend of 0 USD.
What is the dividend yield of Glaukos?
The current dividend yield of Glaukos is .
When does Glaukos pay dividends?
Glaukos pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Glaukos?
Glaukos paid dividends every year for the past 0 years.
What is the dividend of Glaukos?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Glaukos located?
Glaukos is assigned to the 'Health' sector.
Wann musste ich die Aktien von Glaukos kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Glaukos from 10/4/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/4/2024.
When did Glaukos pay the last dividend?
The last dividend was paid out on 10/4/2024.
What was the dividend of Glaukos in the year 2023?
In the year 2023, Glaukos distributed 0 USD as dividends.
In which currency does Glaukos pay out the dividend?
The dividends of Glaukos are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Glaukos
Our stock analysis for Glaukos Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Glaukos Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
